Basics of Follicular Lymphoma
Produced in collaboration with The Leukemia & Lymphoma Society
Support for this patient education program was provided by Genentech.
This program, created in partnership with The Leukemia & Lymphoma Society, shares valuable information with patients and caregivers managing Follicular Lymphoma.
Join us to learn more about the available treatments for Follicular Lymphoma, and to find supportive resources and information for ongoing self‐care.
The session includes an expert panel featuring specialists from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, The Leukemia & Lymphoma Society, and patients who are living with Follicular Lymphoma.
Treatment Options for Untreated Patients with Advanced Stage FL
What else should I do?
John P. Leonard, MD
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Associate Dean for Clinical Research
Weill Cornell Medicine and New York-Presbyterian Hospital
New York, NY
John P. Leonard, MD, is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and associate dean for clinical research at the Weill Cornell Medical College in New York. He is vice chairman for clinical research of the Department of Medicine and associate director of the Meyer Cancer Center at Weill Cornell Medicine and New York Presbyterian Hospital. Dr Leonard’s research focuses on developing novel therapeutic strategies for treating lymphoma and related hematologic malignancies. He is a board member of The Leukemia & Lymphoma Society’s New York City chapter, and has served on the editorial boards of Blood and the Journal of Clinical Oncology. He earned his medical degree at the University of Virginia School of Medicine, Charlottesville.
Anas Younes, MD
Chief, Lymphoma Service,
Memorial Sloan Kettering Cancer Center
Professor, Weill-Cornell Medical College, New York
Anas Younes, MD, is chief of Memorial Sloan Kettering Cancer Center’s Lymphoma Service and a professor at Weill-Cornell Medical College in New York. His interests include Hodgkin lymphoma, non-Hodgkin lymphoma, developing novel targeted therapies, identifying biomarkers for treatment, and participating in clinical trials. Dr Younes led the trials that resulted in the FDA approval of brentuximab vedotin and nivolumab for treating patients with relapsed Hodgkin lymphoma. He served as the principal investigator (PI) of more than 60 clinical trials, has led the National Cancer Institute-funded SPORE (Specialized Programs of Research Excellence) in lymphoma, and is currently the PI of a Specialized Center of Research (SCOR) grant supported by The Leukemia & Lymphoma Society.
Director, Information Resource Center
Leukemia & Lymphoma Society
Meredith Barnhart, LCSW, is the director of The Leukemia & Lymphoma Society (LLS) Information Resource Center. Ms Barnhart oversees 11 information specialists and an operations support coordinator; together, the team provides personalized support to individuals, caregivers, and their loved ones by providing accurate and up-to-date information and resources. Prior to joining LLS, she was employed as a clinical social worker in the Department of Pediatrics at Memorial Sloan Kettering Cancer Center in New York. Ms Barnhart holds a master’s degree in social work from Columbia University and is presently pursuing a PhD in social work from the Graduate School of Social Service at Fordham University. Her area of research focuses on families with multiple incidences of cancers.
- LLS Podcast, The Bloodline with LLS
- Free education videos about survivorship, treatment, disease updates and other topics
- Education: Telephone/Web Programs
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consults for Patients and Caregivers
- What to ask: Questions to ask your treatment team
- Other Support Resources